ZEPOSIA (Ozanimod) for the Treatment of Multiple Sclerosis

Image 2-ZEPOSIA (Ozanimod)
Zeposia is the only approved sphingosine-1-phosphate (S1P) receptor modulator. Credit: Bristol Myers Squibb.